Santhera Pharmaceuticals
SANN.SW
#8555
Rank
$0.11 B
Marketcap
$9.87
Share price
-1.70%
Change (1 day)
-15.50%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -$37.23

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$12.63. In 2022 the company made an earnings per share (EPS) of -$12.63 an increase over its 2021 EPS that were of -$17.73.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-$12.63-28.75%
2021-$17.73-69.23%
2020-$57.62222.64%
2019-$17.86-77.65%
2018-$79.91-5.34%
2017-$84.4252.2%
2016-$55.46-593.67%
2015$11.23-165.72%
2014-$17.10-2.15%
2013-$17.47-81.35%
2012-$93.6915.64%
2011-$81.01145.81%
2010-$32.96-53.37%
2009-$70.68-152.24%
2008$135.30-270.36%
2007-$79.42-33.09%
2006-$118.69